Updated:
1015 Capital
Griendling and Robertson founded 1015 Capital in 2015, bringing together operating experience and private equity discipline to focus on a single thesis:...
1015 Capital
Griendling and Robertson founded 1015 Capital in 2015, bringing together operating experience and private equity discipline to focus on a single thesis: founder-led healthcare services companies that have reached a growth inflection point but lack the internal systems to scale. The firm's name reflects its Philadelphia-area roots, with the partners deliberately maintaining a lean structure outside the traditional financial centers. The firm targets healthcare services and tech-enabled service platforms, deploying capital through control and significant minority equity investments in companies generating between $2 million and $10 million in EBITDA. The strategy concentrates on sub-sectors with recurring-revenue characteristics—behavioral health, home-based care, and revenue-cycle management—where demographic tailwinds and regulatory complexity reward specialized operators. 1015 Capital typically acts as the first institutional capital in a business, structuring partnerships that leave meaningful founder equity in place while building out professional management, financial reporting, and M&A capabilities. The firm has maintained a deliberately small portfolio, consistent with a high-conviction, low-volume deployment model. 1015 Capital operates with a tight internal team, investing out of committed blind-pool funds that provide the partners with the flexibility to hold investments across market cycles. The firm's Narberth location places it physically close to a dense concentration of founder-owned healthcare businesses across the Mid-Atlantic and Northeast, supporting a sourcing model built on direct outreach and operator referrals rather than auction processes. While the firm's total committed capital and deployment pace remain undisclosed, fund documents indicate a focus on making four to six platform investments per fund. Unlike generalist lower-middle-market buyers competing solely on valuation, 1015 Capital's structural differentiator is its functional integration of operating partners into the diligence and post-close process. The firm embeds experienced healthcare operators—not just former consultants or finance professionals—alongside the deal team from the first management meeting, creating a credibility bridge with founders that auction-driven processes rarely replicate. This operating-centric architecture functions as a moat against larger, more capital-rich rivals.
General information
Firm type
Private Equity
Year founded
2015
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Narberth
Corporate office
Narberth, PA, United States
Principals
Harry Griendling
Founder & Managing Partner
William J. R. Robertson
Managing Partner
Sector focus
Frequently asked questions
Who runs investment decisions at 1015 Capital?
Harry Griendling and William J. R. Robertson, the firm's Managing Partners, run the investment process jointly. Both partners sit on the investment committee alongside any senior operating partners brought into a given deal. The structure is flat by design—consistent with a lower-middle-market firm that prioritizes alignment with founders over institutional process.
What size companies does 1015 Capital typically target?
The firm focuses on companies generating between $2 million and $10 million in EBITDA, a segment where founders often face a growth-capacity gap but are too small for institutional-scale private equity platforms. This places 1015 Capital squarely in the lower-middle market, competing on relationship depth and operating expertise rather than on balance-sheet size.
Does 1015 Capital take control positions or minority stakes?
1015 Capital structures both control buyouts and significant minority recapitalizations. The structure in any given deal depends on the founder's objectives. In both scenarios, the firm negotiates for governance rights sufficient to drive the post-close operating playbook, though it typically keeps founders meaningfully invested alongside the fund.
Which healthcare sub-sectors does 1015 Capital explicitly avoid?
The firm's public commentary and fund documents indicate it avoids reimbursement-dependent acute-care models, single-payer-concentrated services, and speculative biotech. The focus stays on services businesses with recurring-revenue profiles—behavioral health, home-based care, and outsourced revenue-cycle functions—where patient volumes are driven by demographics rather than discretionary policy.
How does 1015 Capital source deals differently from larger private equity firms?
The firm runs a direct-sourcing model built on operating-partner networks and proprietary outreach to founder-owned businesses across the Mid-Atlantic and Northeast. By embedding healthcare operators in the first management meeting rather than after close, the firm signals to founders that it understands the operational reality of running a care-delivery business—a positioning that auction-driven processes rarely achieve.
Is 1015 Capital investing from a committed fund or on a deal-by-deal basis?
1015 Capital invests from committed blind-pool funds, which provide the firm with the flexibility to act decisively on proprietary opportunities without the delay of raising capital per deal. The committed structure also signals to founders that the capital is fully available and that the partnership is not contingent on syndication.
What is 1015 Capital's geographic footprint?
The firm's primary sourcing ground is the Mid-Atlantic and Northeastern United States, driven by its Narberth, Pennsylvania headquarters and the personal networks of its partners. While not restricted to the region, the strategy exploits the density of founder-owned healthcare services companies within a three-hour radius, where in-person relationship-building remains central to winning deals.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: